{
  "cik": 1770069,
  "cik_padded": "0001770069",
  "entityName": "MapLight Therapeutics, Inc.",
  "fiscal_years": [
    {
      "accn": "0001193125-26-125072",
      "filed": "2026-03-26",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 473000.0,
        "cash": 46729000.0,
        "eps_diluted": -18.56,
        "free_cash_flow": -138610000.0,
        "net_income": -161152000.0,
        "operating_cash_flow": -138137000.0,
        "operating_income": -169083000.0,
        "stockholders_equity": 458372000.0,
        "total_assets": 479512000.0,
        "total_liabilities": 21140000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.046119745534194935,
        "roa_avg2y": -0.5228574951170291,
        "roa_period_end": -0.3360750095930863,
        "roe_avg2y": -1.2174175807572598,
        "roe_period_end": -0.35157470351592157
      }
    },
    {
      "accn": "0001193125-26-125072",
      "filed": "2026-03-26",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 770000.0,
        "cash": 38253000.0,
        "eps_diluted": -105.38,
        "free_cash_flow": -79585000.0,
        "net_income": -77580000.0,
        "operating_cash_flow": -78815000.0,
        "operating_income": -82946000.0,
        "stockholders_equity": -193628000.0,
        "total_assets": 136916000.0,
        "total_liabilities": 21721000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roa_period_end": -0.5666247918431739,
        "roe_avg2y": 0.4985652912956721
      }
    },
    {
      "accn": "0001193125-26-125072",
      "filed": "2026-03-26",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "stockholders_equity": -117585000.0
      },
      "period_end": "2023-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001193125-26-125072",
    "filed": "2026-03-26",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2834",
  "sic_description": "Pharmaceutical Preparations",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001770069.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001770069.json"
  },
  "ticker": "MPLT"
}